Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.88USD
16 Jan 2018
Change (% chg)

$-0.01 (-0.26%)
Prev Close
$3.89
Open
$3.92
Day's High
$3.97
Day's Low
$3.81
Volume
3,222
Avg. Vol
7,155
52-wk High
$5.55
52-wk Low
$1.41

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.51
Market Cap(Mil.): $43.88
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 207.59 16.63
EPS (TTM): -- -- --
ROI: -- -11.19 33.78
ROE: -- -33.91 17.31

BRIEF-Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11

* Cleveland BioLabs reports third quarter 2017 financial results and development progress

14 Nov 2017

BRIEF-Cleveland BioLabs Q2 loss per share $0.50‍​

* Cleveland BioLabs reports second quarter 2017 financial results and development progress

14 Aug 2017

Earnings vs. Estimates